US5795737A
(en)
*
|
1994-09-19 |
1998-08-18 |
The General Hospital Corporation |
High level expression of proteins
|
US5874304A
(en)
*
|
1996-01-18 |
1999-02-23 |
University Of Florida Research Foundation, Inc. |
Humanized green fluorescent protein genes and methods
|
US6020192A
(en)
*
|
1996-01-18 |
2000-02-01 |
University Of Florida |
Humanized green fluorescent protein genes and methods
|
US6541197B2
(en)
*
|
1996-01-22 |
2003-04-01 |
Human Gene Therapy Research Institute |
Vehicles for stable transfer of green fluorescent protein gene and methods of use for same
|
AR006928A1
(es)
*
|
1996-05-01 |
1999-09-29 |
Pioneer Hi Bred Int |
Una molecula de adn aislada que codifica una proteina fluorescente verde como marcador rastreable para la transformacion de plantas, un metodo para laproduccion de plantas transgenicas, un vector de expresion, una planta transgenica y celulas de dichas plantas.
|
US6593135B2
(en)
|
1996-08-16 |
2003-07-15 |
The State Of Oregon, Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Long wavelength engineered fluorescent proteins
|
US6124128A
(en)
|
1996-08-16 |
2000-09-26 |
The Regents Of The University Of California |
Long wavelength engineered fluorescent proteins
|
US6114148C1
(en)
*
|
1996-09-20 |
2012-05-01 |
Gen Hospital Corp |
High level expression of proteins
|
US6245564B1
(en)
*
|
1997-01-23 |
2001-06-12 |
Cornell Research Foundation, Inc. |
Method for separating cells
|
US6670449B1
(en)
|
1997-02-13 |
2003-12-30 |
Memorial Sloan-Kettering Cancer Center |
Hybrid molecules and their use for optically detecting changes in cellular microenvironments
|
DE69837118T2
(de)
*
|
1997-04-07 |
2007-12-27 |
Fisher Biolmage Aps |
Ein Verfahren zum Screenen von Substanzen hinsichtlich ihres Effekts auf cAMP Spiegel basierend auf intrazellulärer Translokation von PKA
|
US6046925A
(en)
*
|
1997-04-14 |
2000-04-04 |
The Regents Of The University Of California |
Photochromic fluorescent proteins and optical memory storage devices based on fluorescent proteins
|
AU7256498A
(en)
*
|
1997-04-25 |
1998-11-24 |
Wistar Institute Of Anatomy And Biology, The |
Cytolytic t-cell clones against colorectal carcinoma and methods of use thereof
|
US6232523B1
(en)
*
|
1997-04-28 |
2001-05-15 |
Anticancer, Inc. |
Metastasis models using green fluorescent protein (GFP) as a marker
|
US6251384B1
(en)
*
|
1997-04-28 |
2001-06-26 |
Anticancer, Inc. |
Metastasis models using green fluorescent protein (GFP) as a marker
|
US6528271B1
(en)
*
|
1997-06-05 |
2003-03-04 |
Duke University |
Inhibition of βarrestin mediated effects prolongs and potentiates opioid receptor-mediated analgesia
|
US5891646A
(en)
*
|
1997-06-05 |
1999-04-06 |
Duke University |
Methods of assaying receptor activity and constructs useful in such methods
|
US7541151B2
(en)
|
1997-06-05 |
2009-06-02 |
Duke University |
Single-cell biosensor for the measurement of GPCR ligands in a test sample
|
AUPP807899A0
(en)
|
1999-01-08 |
1999-02-04 |
University Of Queensland, The |
Codon utilization
|
WO1999002694A1
(en)
*
|
1997-07-09 |
1999-01-21 |
The University Of Queensland |
Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue
|
US6602677B1
(en)
*
|
1997-09-19 |
2003-08-05 |
Promega Corporation |
Thermostable luciferases and methods of production
|
US6130313A
(en)
*
|
1997-10-02 |
2000-10-10 |
Clontech Laboratories, Inc. |
Rapidly degrading GFP-fusion proteins
|
EP1038009A1
(de)
*
|
1997-12-12 |
2000-09-27 |
The Regents of the University of California |
Methode zur bestimmung des zelltyps
|
DE19811618C1
(de)
*
|
1998-03-17 |
2000-08-31 |
Andreas Jenne |
Ribozym codierende DNA und ein Oligonucleotidsubstrat enthaltende Zusammensetzung und Verfahren zur Messung von Transkriptionsraten
|
AU3366099A
(en)
*
|
1998-03-26 |
1999-10-18 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Drm, a secreted protein with cell growth inhibiting activity, and related methods and compositions
|
EP1925320A3
(de)
|
1998-03-27 |
2008-09-03 |
Prolume, Ltd. |
Luciferasen, fluoreszierende Proteine, Nukleinsäuren zur Kodierung der Luciferasen und der fluoreszierenden Proteine sowie deren Verwendung zur Diagnose, zum Screening mit hohem Durchsatz und zur Behandlung neuartiger Probleme
|
EP1064360B1
(de)
|
1998-03-27 |
2008-03-05 |
Prolume, Ltd. |
Luciferase, gfp fluoreszenzproteine, kodierende nukleinsaüre und ihre verwendung in der diagnose
|
FR2778408A1
(fr)
*
|
1998-05-11 |
1999-11-12 |
Univ Pasteur |
Anticorps recombinants fluorescents
|
US7090976B2
(en)
*
|
1999-11-10 |
2006-08-15 |
Rigel Pharmaceuticals, Inc. |
Methods and compositions comprising Renilla GFP
|
GB9810752D0
(en)
*
|
1998-05-19 |
1998-07-15 |
Glaxo Group Ltd |
Cystosine deaminase gene
|
US6509174B2
(en)
*
|
1998-06-16 |
2003-01-21 |
Ecole Polytechnique Federal De Lausanne (Epfl) |
Cells, genetically modified with optical marker
|
US6924365B1
(en)
|
1998-09-29 |
2005-08-02 |
Transkaryotic Therapies, Inc. |
Optimized messenger RNA
|
US8263402B1
(en)
|
1998-10-19 |
2012-09-11 |
Cornell Research Foundation, Inc. |
Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells
|
US6759237B1
(en)
|
1998-11-05 |
2004-07-06 |
The Trustees Of The University Of Pennsylvania |
Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
|
WO2000028004A1
(en)
*
|
1998-11-10 |
2000-05-18 |
The University Of North Carolina At Chapel Hill |
Virus vectors and methods of making and administering the same
|
US20030087492A1
(en)
|
2001-11-02 |
2003-05-08 |
Promos Technologies, Inc. |
Semiconductor device and method of manufacturing the same
|
US8012682B2
(en)
*
|
1998-12-11 |
2011-09-06 |
Clontech Laboratories, Inc. |
Nucleic acids encoding chromophores/fluorophores and methods for using the same
|
US9834584B2
(en)
*
|
1998-12-11 |
2017-12-05 |
Takara Bio Usa, Inc. |
Nucleic acids encoding chromophores/fluorophores and methods for using the same
|
AUPP807799A0
(en)
*
|
1999-01-08 |
1999-02-04 |
University Of Queensland, The |
Polynucleotide and method
|
US8131053B2
(en)
|
1999-01-25 |
2012-03-06 |
Amnis Corporation |
Detection of circulating tumor cells using imaging flow cytometry
|
US8406498B2
(en)
|
1999-01-25 |
2013-03-26 |
Amnis Corporation |
Blood and cell analysis using an imaging flow cytometer
|
US8885913B2
(en)
|
1999-01-25 |
2014-11-11 |
Amnis Corporation |
Detection of circulating tumor cells using imaging flow cytometry
|
US7450229B2
(en)
|
1999-01-25 |
2008-11-11 |
Amnis Corporation |
Methods for analyzing inter-cellular phenomena
|
JP2002541779A
(ja)
*
|
1999-02-24 |
2002-12-10 |
ザ ジュネラル ホスピタル コーポレーション |
シグナル伝達中間体のクローニング方法
|
DE19915137C2
(de)
*
|
1999-03-26 |
2001-10-18 |
Michael Schaefer |
Verfahren zur Quantifizierung mehrerer Fluorochrome in einer mehrfach gefärbten Probe bei der Fluoreszenzmikroskopie und Verwendungen des Verfahrens
|
US6541244B1
(en)
*
|
1999-06-07 |
2003-04-01 |
Cedars-Sinai Medical Center |
Suppressor of cytokine signaling (SOCS)-3 promoter and methods for its use in genetic therapy in humans
|
JP2003504059A
(ja)
*
|
1999-07-12 |
2003-02-04 |
ジェネンテック・インコーポレーテッド |
発現ベクターと方法
|
US20050005310A1
(en)
*
|
1999-07-12 |
2005-01-06 |
Genentech, Inc. |
Expression vectors and methods
|
US7001995B1
(en)
*
|
1999-08-25 |
2006-02-21 |
Merck & Co., Inc. |
Synthetic human papillomavirus genes
|
US6716614B1
(en)
|
1999-09-02 |
2004-04-06 |
Lexicon Genetics Incorporated |
Human calcium dependent proteases, polynucleotides encoding the same, and uses thereof
|
US6541252B1
(en)
|
2000-05-19 |
2003-04-01 |
Lexicon Genetics Incorporated |
Human kinases and polynucleotides encoding the same
|
US6864355B1
(en)
|
2000-05-02 |
2005-03-08 |
Yale University |
Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
|
EP2308974A3
(de)
|
1999-10-14 |
2011-08-10 |
Clontech Laboratories Inc. |
Aus Anthozoa abgeleitete Chrom-/Fluorproteine sowie Verwendungsverfahren dafür
|
JP2003514550A
(ja)
*
|
1999-11-19 |
2003-04-22 |
コールド スプリング ハーバー ラボラトリー |
ネスチンプロモーターの制御下で蛍光タンパク質を発現するトランスジェニックマウス
|
AU2913801A
(en)
*
|
1999-12-23 |
2001-07-03 |
Cornell Research Foundation Inc. |
A method for isolating and purifying multipotential neural progenitor cells and multipotential neural progenitor cells
|
US20020064842A1
(en)
*
|
2000-06-09 |
2002-05-30 |
Sorge Joseph A. |
Renilla reniformis green fluorescent protein and mutants thereof
|
US6502774B1
(en)
*
|
2000-03-08 |
2003-01-07 |
J + L Fiber Services, Inc. |
Refiner disk sensor and sensor refiner disk
|
US7109315B2
(en)
*
|
2000-03-15 |
2006-09-19 |
Bruce J. Bryan |
Renilla reniformis fluorescent proteins, nucleic acids encoding the fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items
|
CA2301158A1
(en)
*
|
2000-03-24 |
2001-09-24 |
Stephen J. Allen |
Screening methods for compounds useful for modulating lipid metabolism in disease
|
US7037493B2
(en)
|
2000-05-01 |
2006-05-02 |
Cornell Research Foundation, Inc. |
Method of inducing neuronal production in the brain and spinal cord
|
US6686188B2
(en)
*
|
2000-05-26 |
2004-02-03 |
Amersham Plc |
Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle
|
US6656700B2
(en)
*
|
2000-05-26 |
2003-12-02 |
Amersham Plc |
Isoforms of human pregnancy-associated protein-E
|
JP2002045174A
(ja)
*
|
2000-07-31 |
2002-02-12 |
Inst Of Physical & Chemical Res |
ナチュラルキラー細胞増殖法
|
KR100403159B1
(ko)
*
|
2000-08-07 |
2003-10-30 |
광주과학기술원 |
씨-포스 프로모터와 녹색 형광 단백질 유전자의 융합유전자, 이 유전자를 포함하는 벡터 및 이 벡터로형질감염된 재조합 동물 세포
|
KR100393709B1
(ko)
*
|
2000-08-07 |
2003-08-06 |
광주과학기술원 |
재조합 동물 세포주를 이용한 환경 오염 물질의 탐지 방법
|
JP2004267001A
(ja)
*
|
2000-08-16 |
2004-09-30 |
Kansai Tlo Kk |
トランスジェニック哺乳動物及びその作製方法並びにこれを用いた遺伝子機能の解明方法
|
US7879540B1
(en)
|
2000-08-24 |
2011-02-01 |
Promega Corporation |
Synthetic nucleic acid molecule compositions and methods of preparation
|
US20030157643A1
(en)
*
|
2000-08-24 |
2003-08-21 |
Almond Brian D |
Synthetic nucleic acids from aquatic species
|
US20040115659A1
(en)
*
|
2001-08-29 |
2004-06-17 |
Benjamin Geiger |
Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
|
US20020123474A1
(en)
*
|
2000-10-04 |
2002-09-05 |
Shannon Mark E. |
Human GTP-Rho binding protein2
|
EP1334122B1
(de)
*
|
2000-10-12 |
2006-08-23 |
Clontech Laboratories, Inc. |
Nukleinsäuren, die für stichodactylidae chromoproteine kodieren
|
CA2427113A1
(en)
*
|
2000-10-27 |
2002-09-12 |
Lexicon Genetics Incorporated |
Novel human 7tm proteins and polynucleotides encoding the same
|
EP1330524A2
(de)
*
|
2000-10-30 |
2003-07-30 |
Lexicon Genetics Incorporated |
Humane 7tm-proteine und dafür kodierende polynukleotiden
|
US6645761B1
(en)
*
|
2000-12-22 |
2003-11-11 |
Stratagene |
Humanized polynucleotide sequence encoding Renilla mulleri green fluorescent protein
|
US6969597B2
(en)
*
|
2001-02-21 |
2005-11-29 |
Clontech Laboratories, Inc. |
Nucleic acids encoding non aggregating fluorescent proteins and methods for using the same
|
US20050079579A1
(en)
*
|
2001-02-28 |
2005-04-14 |
Guangwen Wei |
Uses of spatial configuration to modulate protein function
|
US20060035327A1
(en)
*
|
2001-02-28 |
2006-02-16 |
Guangwen Wei |
Recombinant super-compound interferon and uses thereof
|
CN1245215C
(zh)
*
|
2001-02-28 |
2006-03-15 |
四川省生物工程研究中心 |
重组高效复合干扰素用作乙型肝炎表面抗原和e抗原抑制剂
|
IL157769A0
(en)
*
|
2001-03-07 |
2004-03-28 |
Xenogen Corp |
Methods of screening for introduction of dna into a target cell
|
JP3929250B2
(ja)
*
|
2001-03-08 |
2007-06-13 |
株式会社ルネサステクノロジ |
半導体装置
|
WO2002077011A2
(en)
*
|
2001-03-12 |
2002-10-03 |
The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of The University Of Oregon |
Oxidation-reduction sensitive green fluorescent protein variants
|
WO2002096924A1
(en)
*
|
2001-05-25 |
2002-12-05 |
Clontech Laboratories, Inc. |
Kindling fluorescent proteins and methods for their use
|
JP3829252B2
(ja)
|
2001-06-08 |
2006-10-04 |
独立行政法人理化学研究所 |
蛍光蛋白質
|
US6780974B2
(en)
*
|
2001-06-12 |
2004-08-24 |
Cellomics, Inc. |
Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors
|
US7393656B2
(en)
|
2001-07-10 |
2008-07-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and compositions for risk stratification
|
US20040096880A1
(en)
*
|
2001-08-07 |
2004-05-20 |
Kmiec Eric B. |
Compositions and methods for the treatment of diseases exhibiting protein misassembly and aggregation
|
WO2003013437A2
(en)
*
|
2001-08-07 |
2003-02-20 |
University Of Delaware |
Compositions and methods for the prevention and treatment of huntington's disease
|
AU2002327433A1
(en)
|
2001-08-10 |
2003-02-24 |
Cornell Research Foundation, Inc. |
Telomerase immortalized human neutral stem cells and phenotypically-restricted progenitor cells
|
AU2002332666B2
(en)
*
|
2001-08-27 |
2006-10-26 |
Syngenta Participations Ag |
Self-processing plants and plant parts
|
KR20040066788A
(ko)
|
2001-08-31 |
2004-07-27 |
더 락커펠러 유니버시티 |
프스포다이에스터레이즈 활성 및 뇌에서프스포다이에스터레이즈 1b 매개되는 신호의 조절
|
DE60223937T2
(de)
*
|
2001-10-12 |
2008-11-27 |
Clontech Laboratories, Inc., Mountain View |
Nukleinsäuren kodierend miteinander verbundene chromo/fluoreszenzdomänen und verfahren zu ihrer verwendung
|
WO2003042401A2
(en)
*
|
2001-11-13 |
2003-05-22 |
Clontech Laboratories, Inc. |
Novel chromophores/fluorophores and methods for using the same
|
EP1456223B1
(de)
*
|
2001-12-19 |
2009-08-12 |
The University Of Chicago |
Schnellreifende fluoreszierende proteine und verfahren zu deren anwendung
|
JP2005514032A
(ja)
*
|
2001-12-26 |
2005-05-19 |
クローンテック ラボラトリーズ インク. |
変異体発色団/蛍光団ならびにそれらの製造法および使用法
|
AU2003209272A1
(en)
*
|
2002-01-16 |
2003-09-02 |
Zyomyx, Inc. |
Engineered binding proteins
|
RU2330886C2
(ru)
*
|
2002-01-22 |
2008-08-10 |
Закрытое Акционерное Общество "Евроген Айпи" |
НОВЫЕ ФЛУОРЕСЦИРУЮЩИЕ БЕЛКИ Aequorea coerulscens И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
|
US6918839B2
(en)
*
|
2002-01-28 |
2005-07-19 |
The Boeing Company |
Damage tolerant shaft
|
US20040005301A1
(en)
*
|
2002-02-12 |
2004-01-08 |
Goldman Steven A. |
Identification and high-yield isolation of human pancreatic islet progenitor and stem cells
|
WO2003070189A2
(en)
*
|
2002-02-15 |
2003-08-28 |
Cornell Research Foundation, Inc. |
Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
|
US20100311954A1
(en)
*
|
2002-03-01 |
2010-12-09 |
Xencor, Inc. |
Optimized Proteins that Target Ep-CAM
|
AU2003228301A1
(en)
*
|
2002-03-06 |
2003-09-22 |
Rigel Pharmaceuticals, Inc. |
Novel method for delivery and intracellular synthesis of sirna molecules
|
US20030182669A1
(en)
*
|
2002-03-19 |
2003-09-25 |
Rockman Howard A. |
Phosphoinositide 3-kinase mediated inhibition of GPCRs
|
US7351542B2
(en)
|
2002-05-20 |
2008-04-01 |
The Regents Of The University Of California |
Methods of modulating tubulin deacetylase activity
|
US7290215B2
(en)
*
|
2002-06-03 |
2007-10-30 |
Microsoft Corporation |
Dynamic wizard interface system and method
|
AU2003267967B2
(en)
*
|
2002-06-18 |
2008-11-20 |
Zymogenetics, Inc. |
Hybrid vector having a cytomegalovirus enhancer and myeloproliferative sarcoma virus promoter
|
EP1539786A4
(de)
*
|
2002-07-10 |
2006-09-06 |
Stratagene California |
HUMANISIERTES, GRÜN FLUORESZIERENDES RENILLA RENIFORMIS-PROTEIN ALS GERüST
|
AU2003274905A1
(en)
*
|
2002-08-20 |
2004-06-23 |
Aeras Global Tuberculosis Vaccine Foundation |
Recombinant double-stranded rna phage, and use of the same
|
WO2004024915A1
(en)
*
|
2002-09-13 |
2004-03-25 |
The University Of Queensland |
Gene expression system based on codon translation efficiency
|
US9453251B2
(en)
|
2002-10-08 |
2016-09-27 |
Pfenex Inc. |
Expression of mammalian proteins in Pseudomonas fluorescens
|
AU2003301883A1
(en)
*
|
2002-10-30 |
2004-06-07 |
University Of Tennessee Research Foundation |
Modified luciferase nucleic acids and methods of use
|
WO2004044203A1
(en)
|
2002-11-12 |
2004-05-27 |
Zakrytoe Aktsionernoe Obschestvo 'evrogen' |
Fluorescent proteins and chromoproteins from non-aequorea hydrozoa species and methods for using same
|
AU2003298674A1
(en)
*
|
2002-11-14 |
2004-06-15 |
Genentech Inc |
Intron fusion construct and method of using for selecting high-expressing production cell lines
|
DE10255852B4
(de)
*
|
2002-11-29 |
2006-06-22 |
Deutsches Institut für Ernährungsforschung |
Verfahren zur Expressionsveränderung von Polypeptiden in rekombinanten Expressionssystemen
|
US7413874B2
(en)
*
|
2002-12-09 |
2008-08-19 |
University Of Miami |
Nucleic acid encoding fluorescent proteins from aquatic species
|
DE03781176T1
(de)
|
2002-12-26 |
2006-06-22 |
Zakrytoe Aktsionernoe Obschestvo "Evrogen" |
Fluoreszenzproteine aus copepoda-speziesund verfahren zur verwendung davon
|
WO2004090115A2
(en)
*
|
2003-04-04 |
2004-10-21 |
Stratagene |
Renilla gfp mutants with increased fluorescent intensity and special shift
|
EP1624748A4
(de)
*
|
2003-05-08 |
2009-01-07 |
Health Research Inc |
Transgenes tiermodell für krebs- und stammzellen
|
US7160698B2
(en)
*
|
2003-05-22 |
2007-01-09 |
University Of Florida Research Foundation, Inc. |
Fluorescent and colored proteins, and polynucleotides that encode these proteins
|
US7335496B2
(en)
*
|
2003-06-05 |
2008-02-26 |
Ajinomoto Co., Inc. |
Method for producing target substance
|
ATE506456T1
(de)
|
2003-06-10 |
2011-05-15 |
David Gladstone Inst |
Verfahren zur behandlung von lentivirusinfektionen
|
KR100577512B1
(ko)
*
|
2003-06-16 |
2006-05-10 |
주식회사 바이오인프라 |
녹색 형광 단백질과 Bfl-1의 융합단백질 또는 이를코딩하는 유전자를 포함하는 세포사멸을 유도하기 위한약학 조성물
|
WO2005012497A2
(en)
*
|
2003-07-29 |
2005-02-10 |
Trellis Bioscience, Inc. |
Translocation tagging
|
DE10336760A1
(de)
*
|
2003-08-08 |
2005-03-03 |
Axaron Bioscience Ag |
Verfahren zur in vivo-Markierung definierter Zelltypen innerhalb eines Gewebeverbands
|
EP2325202B1
(de)
*
|
2003-08-28 |
2014-10-22 |
Superlab Far East Limited |
Verwendungen von Interferonen mit veränderter Raumstruktur
|
US7585647B2
(en)
*
|
2003-08-28 |
2009-09-08 |
Guangwen Wei |
Nucleic acid encoding recombinant interferon
|
KR20150103335A
(ko)
*
|
2003-08-28 |
2015-09-09 |
수퍼랩 파 이스트 리미티드 |
변경된 공간 구조를 갖는 인터페론의 용도
|
US8883147B2
(en)
|
2004-10-21 |
2014-11-11 |
Xencor, Inc. |
Immunoglobulins insertions, deletions, and substitutions
|
US20060134105A1
(en)
*
|
2004-10-21 |
2006-06-22 |
Xencor, Inc. |
IgG immunoglobulin variants with optimized effector function
|
US8399618B2
(en)
|
2004-10-21 |
2013-03-19 |
Xencor, Inc. |
Immunoglobulin insertions, deletions, and substitutions
|
US7481997B1
(en)
|
2004-02-12 |
2009-01-27 |
Montana State University |
Snow mountain virus genome sequence, virus-like particles and methods of use
|
JP4572320B2
(ja)
*
|
2004-02-23 |
2010-11-04 |
財団法人大阪産業振興機構 |
組換えヒト細胞、ならびにその組換えヒト細胞を用いてヒト薬物代謝酵素の誘導および薬物代謝の少なくとも一方を評価する方法
|
US8953866B2
(en)
|
2004-03-16 |
2015-02-10 |
Amnis Corporation |
Method for imaging and differential analysis of cells
|
EP1800124B1
(de)
|
2004-03-16 |
2011-12-21 |
Amnis Corporation |
Auf bildlicher darstellung beruhende quantifizierung molekularer translokation
|
WO2005100387A1
(en)
|
2004-04-07 |
2005-10-27 |
The University Of Chicago |
Monomeric red fluorescent proteins
|
EP1755400A2
(de)
*
|
2004-06-18 |
2007-02-28 |
The University Of Montana |
Aav-vermittelte genabgabe an kochlearzellen
|
US8603824B2
(en)
|
2004-07-26 |
2013-12-10 |
Pfenex, Inc. |
Process for improved protein expression by strain engineering
|
US7728118B2
(en)
*
|
2004-09-17 |
2010-06-01 |
Promega Corporation |
Synthetic nucleic acid molecule compositions and methods of preparation
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
KR101027427B1
(ko)
|
2004-11-12 |
2011-04-11 |
젠코어 인코포레이티드 |
FcRn에 대하여 증가된 결합력을 갖는 Fc 변이체
|
AU2005316476A1
(en)
*
|
2004-12-15 |
2006-06-22 |
University Of Florida Research Foundation, Inc. |
Chimeric vectors
|
US7230080B2
(en)
*
|
2005-02-16 |
2007-06-12 |
University Of Florida Research Foundation, Inc. |
Fluorescent and colored proteins, and polynucleotides that encode these proteins
|
CN101137391B
(zh)
*
|
2005-03-09 |
2012-07-18 |
魏光文 |
重组高效复合干扰素的用途
|
WO2007008943A2
(en)
|
2005-07-08 |
2007-01-18 |
Xencor, Inc. |
Optimized anti-ep-cam antibodies
|
EP1931787A4
(de)
*
|
2005-09-30 |
2010-10-20 |
Univ Montana State |
System zum nachweis von protein-protein-wechselwirkungen
|
CA2665080C
(en)
*
|
2005-10-01 |
2015-11-24 |
Charles Stout |
Regulatable fusion promoters
|
ES2399563T3
(es)
|
2005-11-04 |
2013-04-02 |
Evrogen, Jsc |
Proteínas verdes fluorescentes modificadas y método para la utilización de las mismas
|
CA2634591A1
(en)
*
|
2005-12-22 |
2007-07-05 |
Memorial Sloan-Kettering Cancer Center |
Method for detection of cancer cells using virus
|
BRPI0712914A2
(pt)
*
|
2006-02-27 |
2012-10-09 |
Edenspace System Corp |
colheitas de energia para estoques de alimentação de biocombustìvel aperfeiçoados
|
DK2423315T3
(en)
*
|
2006-06-29 |
2015-04-13 |
Dsm Ip Assets Bv |
A method for obtaining enhanced polypeptide expression
|
US20080004410A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Yu-Chin Lai |
Hydrophilic macromonomers having alpha,beta-conjugated carboxylic terminal group and medical devices incorporating same
|
EP3796002B1
(de)
|
2006-07-14 |
2023-11-22 |
The Regents of The University of California |
Krebsbiomarker und verfahren zur verwendung davon
|
US8680235B2
(en)
*
|
2006-09-22 |
2014-03-25 |
Stowers Institute For Medical Research |
Branchiostoma derived fluorescent proteins
|
US7833527B2
(en)
|
2006-10-02 |
2010-11-16 |
Amgen Inc. |
Methods of treating psoriasis using IL-17 Receptor A antibodies
|
WO2008112226A2
(en)
*
|
2007-03-13 |
2008-09-18 |
Massachusetts Institute Of Technology |
Cre-lox based gene knockdown constructs and methods of use thereof
|
WO2008118445A1
(en)
*
|
2007-03-26 |
2008-10-02 |
Promega Corporation |
Methods to quench light from optical reactions
|
BRPI0810120A2
(pt)
|
2007-04-27 |
2014-11-11 |
Dow Global Technologies Inc |
Processo para selecionar rapidamente hospedeiros microbianos para a identificação de certas cepas com maior rendimento e/ou qualidade na expressão de proteínas heterólogas
|
US9580719B2
(en)
|
2007-04-27 |
2017-02-28 |
Pfenex, Inc. |
Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
|
SI2188313T1
(en)
|
2007-08-21 |
2018-04-30 |
Amgen, Inc. |
HUMAN C-FMS ANTIGEN TRANSFER PROTEIN
|
EP2860247A1
(de)
|
2007-08-21 |
2015-04-15 |
Nodality, Inc. |
Diagnose-, Prognose- und Behandlungsverfahren
|
US20090081715A1
(en)
*
|
2007-09-07 |
2009-03-26 |
Cobalt Technologies, Inc., A Delaware Corporation |
Engineered Light-Emitting Reporter Genes
|
TW200918553A
(en)
|
2007-09-18 |
2009-05-01 |
Amgen Inc |
Human GM-CSF antigen binding proteins
|
EP3181228B1
(de)
|
2007-10-02 |
2020-07-29 |
Labrador Diagnostics LLC |
Modulare poc-vorrichtungen und ihre verwendung
|
US8679749B2
(en)
*
|
2007-11-01 |
2014-03-25 |
The University Of Chicago |
Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation
|
EP2808343B8
(de)
|
2007-12-26 |
2020-01-15 |
Xencor, Inc. |
Fc-Varianten mit veränderter Bindung zu FcRn
|
EP2268825A4
(de)
|
2008-04-09 |
2012-05-02 |
Cobalt Technologies Inc |
Immobilisierte produkttolerante mikroorganismen
|
US8309306B2
(en)
*
|
2008-11-12 |
2012-11-13 |
Nodality, Inc. |
Detection composition
|
JO3382B1
(ar)
|
2008-12-23 |
2019-03-13 |
Amgen Inc |
أجسام مضادة ترتبط مع مستقبل cgrp بشري
|
JP5304275B2
(ja)
*
|
2009-01-29 |
2013-10-02 |
Jnc株式会社 |
アポクライティン−iiをコードするコドン最適化核酸およびその使用方法
|
US20100233733A1
(en)
*
|
2009-02-10 |
2010-09-16 |
Nodality, Inc., A Delaware Corporation |
Multiple mechanisms for modulation of the pi3 kinase pathway
|
EP2396343B1
(de)
|
2009-02-11 |
2017-05-17 |
The University of North Carolina At Chapel Hill |
Modifizierte virusvektoren sowie verfahren zu ihrer herstellung und verwendung
|
WO2010096510A2
(en)
|
2009-02-17 |
2010-08-26 |
Edenspace Systems Corporation |
Tempering of cellulosic biomass
|
US8242248B2
(en)
*
|
2009-03-23 |
2012-08-14 |
Nodality, Inc. |
Kits for multiparametric phospho analysis
|
CN102724993B
(zh)
|
2009-04-17 |
2016-04-27 |
纽约大学 |
靶向tnf家族受体并拮抗tnf作用的肽、组合物、方法及其用途
|
TWI372183B
(en)
*
|
2009-05-05 |
2012-09-11 |
Nat Univ Tsing Hua |
Utilizing shield effect for dopamine detection and reagent development
|
WO2010138971A1
(en)
|
2009-05-29 |
2010-12-02 |
Edenspace Systems Corporation |
Plant gene regulatory elements
|
WO2010151706A1
(en)
*
|
2009-06-26 |
2010-12-29 |
Cobalt Technologies, Inc. |
Integrated system and process for bioproduct production
|
TW201117824A
(en)
|
2009-10-12 |
2011-06-01 |
Amgen Inc |
Use of IL-17 receptor a antigen binding proteins
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
JP2013523184A
(ja)
|
2010-04-15 |
2013-06-17 |
アムジエン・インコーポレーテツド |
ヒトFGF受容体およびβ−KLOTHO結合性タンパク質
|
WO2011139721A1
(en)
|
2010-04-27 |
2011-11-10 |
The Regents Of The University Of California |
Cancer biomarkers and methods of use thereof
|
JP5926242B2
(ja)
|
2010-05-10 |
2016-05-25 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
エンドリボヌクレアーゼ組成物およびその使用方法
|
FR2961375B1
(fr)
|
2010-06-16 |
2016-05-13 |
Inst De Rech Pour Le Dev (Ird) |
Surproduction d'acide jasmonique dans des plantes transgeniques
|
WO2012030738A2
(en)
|
2010-08-30 |
2012-03-08 |
Beckman Coulter, Inc. |
Complex phosphoprotein activation profiles
|
BR112013018656B1
(pt)
|
2011-01-21 |
2021-03-02 |
Labrador Diagnostics Llc |
método para detectar a presença ou concentração de um analito numa amostra de fluido contido num recipiente, e, método de medição da concentração de analito numa amostra de fluido
|
WO2012155071A1
(en)
|
2011-05-12 |
2012-11-15 |
Gilead Biologics, Inc. |
Methods of identifying lysyl oxidase - like - 2 (loxl2) binding partners
|
US9574002B2
(en)
|
2011-06-06 |
2017-02-21 |
Amgen Inc. |
Human antigen binding proteins that bind to a complex comprising β-Klotho and an FGF receptor
|
US20140234330A1
(en)
|
2011-07-22 |
2014-08-21 |
Amgen Inc. |
Il-17 receptor a is required for il-17c biology
|
US8435738B2
(en)
|
2011-09-25 |
2013-05-07 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
US9619627B2
(en)
|
2011-09-25 |
2017-04-11 |
Theranos, Inc. |
Systems and methods for collecting and transmitting assay results
|
US20140170735A1
(en)
|
2011-09-25 |
2014-06-19 |
Elizabeth A. Holmes |
Systems and methods for multi-analysis
|
US9268915B2
(en)
|
2011-09-25 |
2016-02-23 |
Theranos, Inc. |
Systems and methods for diagnosis or treatment
|
US8475739B2
(en)
|
2011-09-25 |
2013-07-02 |
Theranos, Inc. |
Systems and methods for fluid handling
|
US9632102B2
(en)
|
2011-09-25 |
2017-04-25 |
Theranos, Inc. |
Systems and methods for multi-purpose analysis
|
US8840838B2
(en)
|
2011-09-25 |
2014-09-23 |
Theranos, Inc. |
Centrifuge configurations
|
US9664702B2
(en)
|
2011-09-25 |
2017-05-30 |
Theranos, Inc. |
Fluid handling apparatus and configurations
|
ES2806146T3
(es)
|
2011-09-22 |
2021-02-16 |
Amgen Inc |
Proteínas de unión al antígeno CD27L
|
US10012664B2
(en)
|
2011-09-25 |
2018-07-03 |
Theranos Ip Company, Llc |
Systems and methods for fluid and component handling
|
US9250229B2
(en)
|
2011-09-25 |
2016-02-02 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
US9810704B2
(en)
|
2013-02-18 |
2017-11-07 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
EP2788384B1
(de)
|
2011-12-08 |
2017-08-09 |
Amgen Inc. |
Agonistische menschliche lcat-antigenbindende proteine und ihre verwendung in der therapie
|
FR2984076A1
(fr)
|
2011-12-15 |
2013-06-21 |
Inst Rech Developpement Ird |
Surproduction de jasmonates dans des plantes transgeniques
|
JP6406581B2
(ja)
|
2011-12-16 |
2018-10-17 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
オプシンポリペプチドおよびその使用法
|
UY34813A
(es)
|
2012-05-18 |
2013-11-29 |
Amgen Inc |
Proteínas de unión a antígeno dirigidas contra el receptor st2
|
US9040248B2
(en)
|
2012-06-06 |
2015-05-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Kits for detecting and monitoring endocrine disrupting chemicals (EDCs)
|
EP3539563A1
(de)
|
2012-07-19 |
2019-09-18 |
Redwood Bioscience, Inc. |
Für cd22 spezifischer antikörper und verfahren zur verwendung davon
|
KR102076384B1
(ko)
|
2012-08-16 |
2020-02-11 |
아이피어리언 인코포레이티드 |
타우병증을 치료하는 방법
|
WO2014028939A2
(en)
|
2012-08-17 |
2014-02-20 |
California Institute Of Technology |
Targeting phosphofructokinase and its glycosylation form for cancer
|
WO2014042923A1
(en)
|
2012-09-13 |
2014-03-20 |
Indiana University Research & Technology Corporation |
Compositions and systems for conferring disease resistance in plants and methods of use thereof
|
CA3124553A1
(en)
|
2012-10-25 |
2014-05-01 |
Bioverativ Usa Inc. |
Anti-complement c1s antibodies and uses thereof
|
PT2914291T
(pt)
|
2012-11-02 |
2022-05-05 |
Bioverativ Usa Inc |
Anticorpos anti-complemento c1s e suas utilizações
|
TW201425336A
(zh)
|
2012-12-07 |
2014-07-01 |
Amgen Inc |
Bcma抗原結合蛋白質
|
TWI726291B
(zh)
|
2013-01-07 |
2021-05-01 |
英屬維爾京群島商遠東超級實驗室有限公司 |
通過干擾素的經皮和/或經粘膜給藥治療骨癌、皮膚癌、皮下癌、粘膜癌和/或粘膜下癌的方法和組合物
|
JO3519B1
(ar)
|
2013-01-25 |
2020-07-05 |
Amgen Inc |
تركيبات أجسام مضادة لأجل cdh19 و cd3
|
US9920121B2
(en)
|
2013-01-25 |
2018-03-20 |
Amgen Inc. |
Antibodies targeting CDH19 for melanoma
|
AU2014244444A1
(en)
|
2013-03-14 |
2015-09-24 |
Amgen Inc. |
CHRDL-1 antigen binding proteins and methods of treatment
|
US9850297B2
(en)
|
2013-03-15 |
2017-12-26 |
Amgen Inc. |
Secreted frizzle-related protein 5 (SFRP5) binding proteins
|
EP3653642A1
(de)
|
2013-03-15 |
2020-05-20 |
Amgen Research (Munich) GmbH |
Einbettige bindemoleküle mit n-terminalen ab
|
AU2014228924B2
(en)
|
2013-03-15 |
2019-04-18 |
Amgen Inc. |
Human PAC1 antibodies
|
WO2014140368A1
(en)
|
2013-03-15 |
2014-09-18 |
Amgen Research (Munich) Gmbh |
Antibody constructs for influenza m2 and cd3
|
AU2014273966B2
(en)
|
2013-05-30 |
2017-08-31 |
Kiniksa Pharmaceuticals, Ltd. |
Oncostatin M receptor antigen binding proteins
|
PL3007726T3
(pl)
|
2013-06-10 |
2021-01-11 |
Ipierian, Inc. |
Metody leczenia tauopatii
|
US9770461B2
(en)
|
2013-08-02 |
2017-09-26 |
California Institute Of Technology |
Tailored glycopolymers as anticoagulant heparin mimetics
|
US10227370B2
(en)
|
2013-08-02 |
2019-03-12 |
California Institute Of Technology |
Heparan sulfate/heparin mimetics with anti-chemokine and anti-inflammatory activity
|
TW201605896A
(zh)
|
2013-08-30 |
2016-02-16 |
安美基股份有限公司 |
Gitr抗原結合蛋白
|
US11545241B1
(en)
|
2013-09-07 |
2023-01-03 |
Labrador Diagnostics Llc |
Systems and methods for analyte testing and data management
|
TWI688401B
(zh)
|
2013-09-13 |
2020-03-21 |
美商安進公司 |
用於治療骨髓性白血病的表觀遺傳因子與靶向cd33及cd3之雙特異性化合物的組合
|
US20160289309A1
(en)
|
2013-11-27 |
2016-10-06 |
Ipierian, Inc. |
Methods of treating a tauopathy
|
US9682123B2
(en)
|
2013-12-20 |
2017-06-20 |
The Trustees Of Columbia University In The City Of New York |
Methods of treating metabolic disease
|
DK3447493T3
(da)
*
|
2014-01-07 |
2020-08-17 |
Bioatla Llc |
Proteinrettede ortologer
|
JP6619745B2
(ja)
|
2014-02-20 |
2019-12-11 |
アラーガン、インコーポレイテッドAllergan,Incorporated |
補体成分c5抗体
|
US9796776B2
(en)
|
2014-02-27 |
2017-10-24 |
Allergan, Inc. |
Complement factor Bb antibodies
|
SI3157956T1
(sl)
|
2014-06-19 |
2020-06-30 |
Regeneron Pharmaceuticals, Inc. |
Nehumane živali, ki imajo humaniziran gen programirane celične smrti 1
|
WO2016007886A1
(en)
|
2014-07-11 |
2016-01-14 |
Northwestern University |
Yeast-based biosensor
|
WO2016014621A1
(en)
*
|
2014-07-22 |
2016-01-28 |
The Regents Of The University Of California |
Endosomal escape domains for delivery of macromolecules into cells
|
AR101400A1
(es)
|
2014-07-31 |
2016-12-14 |
Amgen Res (Munich) Gmbh |
Constructo de anticuerpo de cadena individual biespecífico con distribución mejorada de tejido
|
UY36245A
(es)
|
2014-07-31 |
2016-01-29 |
Amgen Res Munich Gmbh |
Constructos de anticuerpos para cdh19 y cd3
|
US11661462B2
(en)
|
2014-07-31 |
2023-05-30 |
Amgen Research (Munich) Gmbh |
Optimized cross-species specific bispecific single chain antibody contructs
|
WO2016040767A2
(en)
|
2014-09-12 |
2016-03-17 |
Amgen Inc. |
Chrdl-1 epitopes and antibodies
|
KR102617691B1
(ko)
|
2014-12-05 |
2023-12-27 |
리제너론 파마슈티칼스 인코포레이티드 |
인간화 분화 클러스터 47 유전자를 가진 비인간 동물
|
EP3227687A4
(de)
|
2014-12-05 |
2018-10-24 |
Prelude, Inc. |
Dcis-wiederauftreten und invasiver brustkrebs
|
SI3230320T1
(sl)
|
2014-12-09 |
2021-02-26 |
Regeneron Pharmaceuticals, Inc. |
Nehumane živali s humaniziranim genom označevalca pripadnosti 274
|
CA2976074A1
(en)
|
2015-02-09 |
2016-08-18 |
Memorial Sloan Kettering Cancer Center |
Multi-specific antibodies with affinity for human a33 antigen and dota metal complex and uses thereof
|
KR20180023892A
(ko)
|
2015-04-17 |
2018-03-07 |
암젠 리서치 (뮌헨) 게엠베하 |
Cdh3 및 cd3에 대한 이중 특이성 항체 작제물
|
WO2016186948A1
(en)
|
2015-05-15 |
2016-11-24 |
Albert Einstein College Of Medicine, Inc. |
Gfp-derived fusion tags for protein expression
|
WO2016189118A1
(en)
|
2015-05-28 |
2016-12-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of prognosis and treatment of patients suffering from acute myeloid leukemia
|
WO2016196185A1
(en)
|
2015-05-29 |
2016-12-08 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals having a disruption in a c9orf72 locus
|
TWI829617B
(zh)
|
2015-07-31 |
2024-01-21 |
德商安美基研究(慕尼黑)公司 |
Flt3及cd3抗體構築體
|
TWI717375B
(zh)
|
2015-07-31 |
2021-02-01 |
德商安美基研究(慕尼黑)公司 |
Cd70及cd3抗體構築體
|
TW202346349A
(zh)
|
2015-07-31 |
2023-12-01 |
德商安美基研究(慕尼黑)公司 |
Dll3及cd3抗體構築體
|
TWI796283B
(zh)
|
2015-07-31 |
2023-03-21 |
德商安美基研究(慕尼黑)公司 |
Msln及cd3抗體構築體
|
TWI744242B
(zh)
|
2015-07-31 |
2021-11-01 |
德商安美基研究(慕尼黑)公司 |
Egfrviii及cd3抗體構築體
|
EP3344654B1
(de)
|
2015-09-02 |
2020-10-21 |
Immutep S.A.S. |
Anti-lag-3-antikörper
|
RU2745403C2
(ru)
|
2015-11-20 |
2021-03-24 |
Регенерон Фармасьютикалз, Инк. |
Животные, отличные от человека, имеющие гуманизированный ген активации лимфоцитов-3
|
EP3394104A2
(de)
|
2015-12-23 |
2018-10-31 |
Amgen Inc. |
Verfahren zur behandlung oder linderung von stoffwechselstörungen mit bindenden proteinen für magensäureinhibierenden peptidrezeptor (gipr) in kombination mit glp-1-agonisten
|
IL260526B2
(en)
|
2016-01-13 |
2023-10-01 |
Regeneron Pharma |
Rodents with an engineered heavy chain diversity region
|
TWI797073B
(zh)
|
2016-01-25 |
2023-04-01 |
德商安美基研究(慕尼黑)公司 |
包含雙特異性抗體建構物之醫藥組合物
|
EA039859B1
(ru)
|
2016-02-03 |
2022-03-21 |
Эмджен Рисерч (Мюник) Гмбх |
Биспецифические конструкты антител, связывающие egfrviii и cd3
|
EP4039709A1
(de)
|
2016-02-03 |
2022-08-10 |
Amgen Research (Munich) GmbH |
Bcma- und cd3-bispezifische t-zell-aktivierende antikörperkonstrukte
|
IL260920B
(en)
|
2016-02-03 |
2022-09-01 |
Amgen Res Munich Gmbh |
Constructs of psma and cd3 bispecific antigens that bind to t-cells, preparations containing them and uses thereof
|
RU2742354C2
(ru)
|
2016-02-04 |
2021-02-05 |
Регенерон Фармасьютикалз, Инк. |
Животные, отличные от человека, имеющие сконструированный ген angptl8
|
CA3014208A1
(en)
|
2016-02-16 |
2017-08-24 |
Regeneron Pharamaceuticals, Inc. |
Non-human animals having a mutant kynureninase gene
|
JOP20170091B1
(ar)
|
2016-04-19 |
2021-08-17 |
Amgen Res Munich Gmbh |
إعطاء تركيبة ثنائية النوعية ترتبط بـ cd33 وcd3 للاستخدام في طريقة لعلاج اللوكيميا النخاعية
|
JP7026678B2
(ja)
|
2016-09-30 |
2022-02-28 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
C9orf72座位中にヘキサヌクレオチドリピート伸長を有する非ヒト動物
|
US11280790B2
(en)
*
|
2016-10-04 |
2022-03-22 |
Svar Life Science Ab |
System and products for improved quantification of ADCC activity
|
MX2019005256A
(es)
|
2016-11-04 |
2019-08-05 |
Regeneron Pharma |
Animales no humanos que tienen un locus de la cadena ligera lambda de inmunoglobulina modificado geneticamente.
|
SG10201914064QA
(en)
|
2017-01-06 |
2020-03-30 |
Eutilex Co Ltd |
Anti-human 4-1 bb antibodies and use thereof
|
JOP20190177A1
(ar)
|
2017-01-17 |
2019-07-16 |
Amgen Inc |
طريقة لعلاج أو تحسين اضطرابات أيضية باستخدام مساعدات مستقبل glp-1 مقترنة بمناهضات لمستقبل ببتيد مثبط معوي (gipr)
|
JOP20190189A1
(ar)
|
2017-02-02 |
2019-08-01 |
Amgen Res Munich Gmbh |
تركيبة صيدلانية ذات درجة حموضة منخفضة تتضمن بنيات جسم مضاد يستهدف الخلية t
|
CN110520157A
(zh)
|
2017-02-09 |
2019-11-29 |
纪念斯隆凯特琳癌症中心 |
抗-kir3dl1抗体
|
JP2020508636A
(ja)
|
2017-02-10 |
2020-03-26 |
ユーティレックス カンパニー リミテッド |
IFN−γ誘導性制御性T細胞転換性抗癌(IRTCA)抗体およびその使用
|
US11028166B2
(en)
|
2017-02-16 |
2021-06-08 |
Sonnet Bio Therapeutics |
Albumin binding domain fusion proteins
|
AU2018224227A1
(en)
|
2017-02-27 |
2019-08-29 |
Regeneron Pharmaceuticals, Inc. |
Non-human animal models of Retinoschisis
|
KR20190141243A
(ko)
|
2017-05-05 |
2019-12-23 |
암젠 인크 |
개선된 저장 및 투여를 위한 이중특이적 항체 구축물을 포함하는 약제학적 조성물
|
JOP20190259A1
(ar)
|
2017-05-31 |
2019-10-31 |
Amgen Inc |
بروتينات ربط مولد ضد مضادة لـ jagged1
|
AR111842A1
(es)
|
2017-06-02 |
2019-08-21 |
Amgen Inc |
Antagonistas de péptido pac1
|
MX2019013919A
(es)
|
2017-06-20 |
2020-01-21 |
Amgen Inc |
Metodo para tratar o mejorar trastornos metabolicos con proteinas de union para el receptor peptidico inhibidor gastrico (gipr) en combinacion con agonistas de glp-1.
|
MX2020001327A
(es)
|
2017-08-04 |
2020-03-20 |
Amgen Inc |
Metodo de conjugacion de cys-acm.
|
CN111432635B
(zh)
|
2017-12-05 |
2022-10-21 |
瑞泽恩制药公司 |
具有经工程改造的免疫球蛋白λ轻链的非人动物以及所述非人动物的用途
|
US20210163592A1
(en)
|
2017-12-11 |
2021-06-03 |
Amgen Inc |
Continuous manufacturing process for bispecific antibody products
|
TW201940518A
(zh)
|
2017-12-29 |
2019-10-16 |
美商安進公司 |
針對muc17和cd3之雙特異性抗體構建體
|
US11905518B2
(en)
|
2018-02-12 |
2024-02-20 |
Curators Of The University Of Missouri |
Small auxin upregulated (SAUR) gene for the improvement of root system architecture, waterlogging tolerance, drought resistance and yield in plants and methods of uses
|
MX2020013652A
(es)
|
2018-06-14 |
2022-04-21 |
Regeneron Pharma |
Animales no humanos con capacidad de reordenamiento dh-dh en las secuencias codificantes de la cadena pesada de inmunoglobulina.
|
MA53325A
(fr)
|
2018-07-30 |
2021-06-09 |
Amgen Inc |
Administration prolongée d'une construction d'anticorps bispécifique se liant à cd33 et cd3
|
CN112512581A
(zh)
|
2018-08-03 |
2021-03-16 |
安进研发(慕尼黑)股份有限公司 |
针对cldn18.2和cd3的抗体构建体
|
EP3850368A4
(de)
|
2018-09-14 |
2022-11-23 |
Prelude Corporation |
Verfahren zur auswahl zur behandlung von subjekten mit risiko auf invasiven brustkrebs
|
TW202028239A
(zh)
|
2018-09-28 |
2020-08-01 |
美商安進公司 |
針對可溶性bcma之抗體
|
WO2020077212A1
(en)
|
2018-10-11 |
2020-04-16 |
Amgen Inc. |
Downstream processing of bispecific antibody constructs
|
JP2022512860A
(ja)
|
2018-11-06 |
2022-02-07 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
白血病幹細胞を根絶することによる急性骨髄性白血病の治療のための方法および医薬組成物
|
US11690362B2
(en)
|
2018-12-20 |
2023-07-04 |
Regeneran Pharmaceuticals, Inc. |
Nuclease-mediated repeat expansion
|
MA54657A
(fr)
|
2019-01-03 |
2021-11-10 |
Invetx Inc |
Compositions pour augmenter la demi-vie d'un agent thérapeutique chez les chiens et procédés d'utilisation
|
US20220330532A1
(en)
|
2019-06-05 |
2022-10-20 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals having a limited lambda light chain repertoire expressed from the kappa locus and uses thereof
|
MX2021014644A
(es)
|
2019-06-13 |
2022-04-06 |
Amgen Inc |
Control de perfusion basado en biomasa automatizado en la fabricacion de productos biologicos.
|
WO2021035325A1
(pt)
|
2019-08-27 |
2021-03-04 |
Fundação Oswaldo Cruz |
Receptáculo proteico, polinucleotideo, vetor, cassete de expressão, célula, método para produção do receptáculo, método de identificação de patógenos ou de diagnóstico de doenças, uso do receptáculo, e, kit diagnóstico
|
CA3152946A1
(en)
|
2019-09-10 |
2021-03-18 |
Amgen Inc. |
Purification method for bispecific antigen-binding polypeptides with enhanced protein l capture dynamic binding capacity
|
WO2021097344A1
(en)
|
2019-11-13 |
2021-05-20 |
Amgen Inc. |
Method for reduced aggregate formation in downstream processing of bispecific antigen-binding molecules
|
WO2021150824A1
(en)
|
2020-01-22 |
2021-07-29 |
Amgen Research (Munich) Gmbh |
Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
|
WO2021188851A1
(en)
|
2020-03-19 |
2021-09-23 |
Amgen Inc. |
Antibodies against mucin 17 and uses thereof
|
BR112022022922A2
(pt)
|
2020-05-11 |
2023-01-17 |
Invetx Inc |
Composições para aumentar a meia-vida de um agente terapêutico em caninos e métodos de uso
|
JP2023527293A
(ja)
|
2020-05-19 |
2023-06-28 |
アムジエン・インコーポレーテツド |
Mageb2結合構築物
|
JP2023527972A
(ja)
|
2020-05-29 |
2023-07-03 |
アムジエン・インコーポレーテツド |
Cd33及びcd3に結合する二重特異性コンストラクトの有害作用軽減投与
|
WO2022008488A1
(en)
|
2020-07-06 |
2022-01-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of slamf1 as a biomarker in colorectal cancer
|
MX2023000500A
(es)
|
2020-07-10 |
2023-04-12 |
Invetx Inc |
Composiciones para aumentar la semivida de un agente terapeutico en felinos y modos de uso.
|
WO2022013256A1
(en)
|
2020-07-15 |
2022-01-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Use of cd160 as a biomarker in acute myeloid leukemia
|
TW202233679A
(zh)
|
2020-11-06 |
2022-09-01 |
德商安美基研究(慕尼黑)公司 |
選擇性地與cldn6和cd3結合的多肽構建體
|
CA3200317A1
(en)
|
2020-11-06 |
2022-05-12 |
Amgen Inc. |
Multitargeting bispecific antigen-binding molecules of increased selectivity
|
MX2023005323A
(es)
|
2020-11-06 |
2023-05-19 |
Amgen Inc |
Construcciones polipeptidicas que se unen a cd3.
|
US20230406887A1
(en)
|
2020-11-06 |
2023-12-21 |
Amegen Inc. |
Antigen binding domain with reduced clipping rate
|
AU2022210423A1
(en)
|
2021-01-20 |
2023-07-06 |
Nautilus Subsidiary, Inc. |
Methods for biomolecule quantitation
|
TW202313681A
(zh)
|
2021-04-02 |
2023-04-01 |
美商安進公司 |
Mageb2結合構建體
|
US20220331241A1
(en)
|
2021-04-16 |
2022-10-20 |
Regeneron Pharmaceuticals, Inc. |
Treatment of x-linked juvenile retinoschisis
|
CN117279947A
(zh)
|
2021-05-06 |
2023-12-22 |
安进研发(慕尼黑)股份有限公司 |
用于在增殖性疾病中使用的靶向cd20和cd22的抗原结合分子
|
WO2023064871A1
(en)
|
2021-10-14 |
2023-04-20 |
Asimov Inc. |
Integrases, landing pad architectures, and engineered cells comprising the same
|
WO2023086822A2
(en)
|
2021-11-09 |
2023-05-19 |
Asimov Inc. |
Stable production systems for aav vector production
|
TW202346368A
(zh)
|
2022-05-12 |
2023-12-01 |
德商安美基研究(慕尼黑)公司 |
具有增加的選擇性的多鏈多靶向性雙特異性抗原結合分子
|
US20240102045A1
(en)
|
2022-07-19 |
2024-03-28 |
Regeneron Pharmaceuticals, Inc. |
Vectors, genetically modified cells, and genetically modified non-human animals comprising the same
|
WO2024059675A2
(en)
|
2022-09-14 |
2024-03-21 |
Amgen Inc. |
Bispecific molecule stabilizing composition
|